Choon Ok Kim

512 total citations
48 papers, 376 citations indexed

About

Choon Ok Kim is a scholar working on Surgery, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Choon Ok Kim has authored 48 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 13 papers in Oncology and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Choon Ok Kim's work include Drug Transport and Resistance Mechanisms (11 papers), Diabetes Treatment and Management (7 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Choon Ok Kim is often cited by papers focused on Drug Transport and Resistance Mechanisms (11 papers), Diabetes Treatment and Management (7 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Choon Ok Kim collaborates with scholars based in South Korea and United States. Choon Ok Kim's co-authors include Min Soo Park, Jae‐Yong Chung, Duk‐Chul Lee, Sung Kweon Cho, Chung Mo Nam, Ji‐Won Lee, Youn Nam Kim, Joon Chang, Chin Kim and Jina Jung and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Nutrients.

In The Last Decade

Choon Ok Kim

48 papers receiving 366 citations

Peers

Countries citing papers authored by Choon Ok Kim

Since Specialization

Citations

This map shows the geographic impact of Choon Ok Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Choon Ok Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Choon Ok Kim more than expected).

Fields of papers citing papers by Choon Ok Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Choon Ok Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Choon Ok Kim. The network helps show where Choon Ok Kim may publish in the future.

Co-authorship network of co-authors of Choon Ok Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Choon Ok Kim. A scholar is included among the top collaborators of Choon Ok Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Choon Ok Kim. Choon Ok Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Pharmacokinetics, pharmacodynamics, and safety of izuforant, an H4R inhibitor, in healthy subjects: A phase I single and multiple ascending dose study	Clinical and Translational Science	Choon Ok Kim, Youn Nam Kim et al.	3
2	The Association between Serum Lipid Levels and Tinnitus Prevalence and Severity in Korean Elderly: A Nationwide Population-Based Cross-Sectional Study	Yonsei Medical Journal	Duk‐Chul Lee, Choon Ok Kim et al.	6
3	Prediction of herb–drug interaction between hyperforin and sedative hypnotics (zolpidem, alprazolam, and midazolam) using physiologically-based pharmacokinetic modeling	Molecular & Cellular Toxicology	Anna Shin, Sunyoung Cho et al.	1
4	Pharmacokinetic and pharmacodynamic drug–drug interactions between evogliptin and empagliflozin or dapagliflozin in healthy male volunteers	Clinical and Translational Science	Choon Ok Kim, Min Soo Park et al.	1
5	Evaluation of pharmacokinetic interactions between lobeglitazone, empagliflozin, and metformin in healthy subjects	Translational and Clinical Pharmacology	Hee Young Kim, Choon Ok Kim et al.	1
6	The effects of long-term cumulative HbA1c exposure on the development and onset time of dementia in the patients with type 2 diabetes mellitus: Hospital based retrospective study (2005–2021)	Diabetes Research and Clinical Practice	Sunyoung Cho, Choon Ok Kim et al.	4
7	Effect of Rifampicin on the Pharmacokinetics of Evogliptin in Healthy Volunteers	Drug Design Development and Therapy	Choon Ok Kim, Kyungsoo Park et al.	2
8	Coagulant Effect and Tolerability of Yeast-Produced Recombinant Batroxobin in Healthy Adult Subjects	Clinical Drug Investigation	Chan‐Wha Kim, Min Soo Park et al.	5
9	Comparison of biosimilar filgrastim with a reference product: pharmacokinetics, pharmacodynamics, and safety profiles in healthy volunteers	Drug Design Development and Therapy	Choon Ok Kim, Kwang-Seok Seo et al.	1
10	A comparison of the pharmacokinetic and pharmacodynamic properties of nitroglycerin according to the composition of the administration set	Medicine	Choon Ok Kim, Ji Young Min et al.	2
11	Comparison of Pharmacokinetics and Safety of a Fixed-dose Combination of Rosuvastatin and Ezetimibe Versus Separate Tablets in Healthy Subjects	Clinical Therapeutics	Min Soo Park, Jina Jung et al.	14
12	Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the <em>SLCO1B1</em> or <em>CYP2C9</em> genetic polymorphism affect these drug interactions?	Drug Design Development and Therapy	Choon Ok Kim, Hohyun Kim et al.	12
13	Pharmacokinetics, pharmacodynamics and safety of CKD-519, a CETP inhibitor, in healthy subjects	Drug Design Development and Therapy	Choon Ok Kim, Yeon‐Joo Kim et al.	3
14	Pharmacokinetic Interaction Between Amlodipine and Lobeglitazone, a Novel Peroxisome Proliferator–activated Receptor-γ Agonist, in Healthy Subjects	Clinical Therapeutics	Choon Ok Kim, Chin Kim et al.	11
15	Effect of Ketoconazole on Lobeglitazone Pharmacokinetics in Korean Volunteers	Clinical Therapeutics	Choon Ok Kim, Youn Nam Kim et al.	5
16	Influence of Hepatic Dysfunction on the Pharmacokinetics and Safety of Fimasartan	Journal of Cardiovascular Pharmacology	Choon Ok Kim, Sook Jin Seong et al.	8
17	Functional characterization of MATE2-K genetic variants and their effects on metformin pharmacokinetics	Pharmacogenetics and Genomics	Jae‐Yong Chung, Sung Kweon Cho et al.	19
18	Influence of ABCC2, SLCO1B1, and ABCG2 Polymorphisms on the Pharmacokinetics of Olmesartan	Journal of Cardiovascular Pharmacology	Choon Ok Kim, Sung Kyung Cho et al.	10
19	Impact of ABCC2, ABCG2 and SLCO1B1 Polymorphisms on the Pharmacokinetics of Pitavastatin in Humans	Drug Metabolism and Pharmacokinetics	Choon Ok Kim, Sung Kweon Cho et al.	40
20	Is abdominal obesity associated with the 2009 influenza A (H1N1) pandemic in Korean school‐aged children?	Influenza and Other Respiratory Viruses	Choon Ok Kim, Chung Mo Nam et al.	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact